Hydrocortisone butyrate Cream — Class II drug recall D-0054-2021
Terminated recall by Bausch Health Companies, Inc., reported 2020-11-04, distributed nationwide. SUBPOTENT DRUG
| Recall number | D-0054-2021 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Bausch Health Companies, Inc., Bridgewater, NJ, United States |
| Recall initiated | 2020-07-13 |
| Classified | 2020-10-26 |
| Reported by FDA | 2020-11-04 |
| Terminated | 2022-03-03 |
| Distributed | Nationwide (US) |
| Quantity | 35,424 units |
| Reason classes | potency |
| NDC | 68682-0270-15 |
| Lot numbers | 18125C, 19079B, 19142B, 19167B |
| Expiration dates | 2020-09, 2021-05, 2021-09, 2021-10 |
Product
Hydrocortisone butyrate Cream, 0.1%, 15-gram tubes, Rx Only, Manufactured for Oceanside Pharmaceuticals a division of Valeant Pharmaceuticals North America LLC Bridgewater, NJ 08807 USA, By: Ferndale Laboratories, Inc. Ferndale, MI 48220, NDC 68682-270-15
Reason for recall
SUBPOTENT DRUG
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0054-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.